Ultragenyx Pharmaceutical
Christina Wyman currently serves as Associate Director of Pharmacovigilance Operations and Compliance at Ultragenyx since March 2024. Prior to this role, Wyman held various positions at Novavax, including Head of Post-Marketing GVS Operations and Associate Director of Global Vaccine Safety Operations from December 2022 to March 2024. Wyman also worked as Associate Director of Safety and Pharmacovigilance at Cidara Therapeutics from August 2021 to December 2022 and spent over 14 years at Jazz Pharmaceuticals in roles such as Senior Manager of GCM Operational Excellence and Interim Head of Global Case Management. Earlier experience includes a brief tenure at Scios as a Contract DSA and a team lead position at Johnson & Johnson. Wyman holds a Bachelor's degree in Biology from the University of California, Santa Cruz and is currently pursuing a Master of Healthcare Administration at the University of Phoenix.
This person is not in any teams
This person is not in any offices